Stephen T. Worland - 20 Jun 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
President and Chief Executive, Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
Issuer symbol
EFTR on OTC
Transactions as of
20 Jun 2022
Net transactions value
$0
Form type
4
Filing time
22 Jun 2022, 16:13:41 UTC
Previous filing
16 Jun 2022
Next filing
16 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +520,674 $0.000000 520,674 20 Jun 2022 Common Stock 520,674 $1.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests 50% on June 20, 2023, and in 12 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.